Sponsor pipeline

City of Hope Medical Center clinical trial pipeline

Get alerts when City of Hope Medical Center's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

48 trials changed in the last 30 days: 5 stopped, 31 with notable changes, 12 with minor changes only.

  1. Notable

    Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant · Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

    Primary and study completion pushed from Apr 5, 2029 to Nov 5, 2031

    City of Hope Medical CenterPhase 2 NCT07582172 Registry history of NCT07582172 on ClinicalTrials.gov (opens the registry)

Show 12 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-25 NCT07842965 CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and… Phase 1 Not Yet Recruiting

Active trials by phase

Early Phase 1
11
Phase 1
106
Phase 1/2
14
Phase 2
84
Phase 3
5
Phase 4
1
Not charted: 107 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 45

Get alerts when City of Hope Medical Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free